chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vision blurry/foggy all morning; Very nauseas; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FA7485) via an unspecified route of administration in the left arm on 08Sep2021 at 13:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had not received any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number : FC3184) via an unspecified route of administration on 17Aug2021 at 1200 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. On 09Sep2021 at 10:00, the patient reported vision was blurry/foggy all morning and got better in the afternoon and felt very nauseas but could not puke. The events did not result in a doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the events vision blurry/foggy all morning and very nauseas were resolving at the time of this report.
Headache. Chills/shaking. Numbness on the right side of the head and face. Discomfort in the right arm and foot. Vision blurred in both eyes but stronger in the right. Dry right eye and difficulty having movement and blinking. On Thursday 4-01-2021 more acute symptoms, headache and severe chest pain as a consequence I had to go to the emergency room. And to this day my symptoms continue.
his arm really hurt; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient experienced pain in arm after getting Shingrix vaccine. No other information was reported. This case has been linked with US2020081798, reported by same reporter.
Horrible red rash with big welts all over her head, arms, legs, back and front.; Horrible red rash with big welts all over her head, arms, legs, back and front.; This is a spontaneous report from a contactable consumer (patient). This consumer reported similar events for 2 patients. This is 1st of 2 reports. A 93-year-old non-pregnant female patient received bnt162b2 (PFIZER COVID 19, Solution for Injection, Lot Number were not reported) via an unknown route of administration, administered in arm left on 03Feb2021 14:00 (at the age of 93-years-old) as dose 2, single for COVID-19 immunisation. Medical history included high blood pressure and high cholesterol on an unspecified date. No Known allergies. Prior to vaccination, patient had not Covid. Post vaccination, the patient had not tested Covid. The patient previously received bnt162b2 (PFIZER COVID 19, lot unknown), administered in left arm on 13Jan2021 03:30 (at the age of 93-years-old) as dose 1 for COVID-19 immunisation. No other vaccine received in four weeks. Concomitant medication included amlodipine (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), carvedilol (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN), all for an unknown indication, from an unspecified date and unknown if ongoing. It was reported that horrible red rash with big welts all over her head, arms, legs, back and front. This came on exactly one week after the 2nd vaccine dose on 10Feb2021. Her doctor face timed her the same day and prescribe Prednisone 40 mg and Benadryl. She went to the doctors today 11Feb2021 and the doctor said it was a bad reaction to the covid 19 Pfizer vaccine. She had another patient with the exact same rash after the vaccine. The event resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment as prednisone 40 mg and Benadryl. The outcome of the events was not recovered.  Follow-up attempts completed. No further information expected.; Sender's Comments: Linked Report(s) : PFIZER INC-2021187174 same reporter, product and AE, different patient
The shot to my upper left arm, at the time of administration, caused no pain. Immediately afterward I went home and rested.  By early evening, a sensation of tightness and pain began in my upper left shoulder and quickly spread across the top of my shoulder into my neck, left chest, around to my left shoulder blade, and even briefly into my left jaw.  This progressed, and I found I was unable to take a deep breath without pain in my chest.  Other symptoms I had were chills, fever to 99.5, fatigue, and weakness to the point of tremor. After 3 days I remembered I had Ativan 1 mg tablets originally prescribed by my cardiologist, so I tried taking 0.25 mg Ativan (which is all I ever need), and this did help my breathing for the next 24 hours or so.  A couple nights after that  I tried one Tylenol 500 mg capsule instead of the Ativan, and it also helped the pain, so I presumed it was not heart related.  However, the pain was scary and quite debilitating, and I am wondering if it is some sort of brachial neuritis. I also tried my chiropractor yesterday, 1/7/22, but the pain has returned today, milder, but persistent.
Dizziness after 2nd shot.  Also arms tingling after 1st dose 4/13/21 still not gone away.
Markedly swollen area at site of injection almost immediately, then next AM woke up with vascular patches on extremities/face, ears. Very, very itchy-worsening.
Muscle soreness Headache Chills Fatigue Nasal congestion Swelling
Information has been received from a pharmacist referring to a patient of unknown age and gender. On 20-JAN-2015 the patient was vaccinated with a dose of improperly stored ZOSTAVAX (lot#, dosage and route unspecified). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
New onset focal seizures on the left upper extremity. Hospitalized for 24 hours, loaded with phenobarbital, patient s/p intrauterine stroke.
1/4/23 Pt was notified the incident right after the injection, and pt was observed for 15 mins and then left without any discomfort/complaints.   1/5/23 I called pt to see how she was doing. Pt states she has mild headache, feeling tired, and some pain in the injection site. Denied fever, SOB, and any other symptoms. Pt was advised to drink a lot of fluid and rest more, and should seek medical help if symptoms worsen. Pt understood verbally.
Expired vaccine administered. Vaccine expiration 05/06/2017 and vaccine administered on 06/19/2017.
Patient stating having allergic reaction to Shingrix vaccine. Experienced redness, swelling on left arm and cheek. Went to emergency room after taking Benadryl and did not help as  symptoms got worse. At ER patient received injection that helped with swelling, only remains redness on lower area of vaccine.
Headache, Fever, CoughWheeze, Body aches, loss of appetite, fatigue Narrative:
Approximately 30 minutes after injections were given child developed a local reaction of redness, firmness, swelling and pain at injection site. Affected area was approximately 6x3.5 cm of firm redness surrounded by blotchiness, Mother returned to HD with child who was examined by MD. No SS of systemic reaction. Ice was applied, pain relievers advised. Mother instructed to notify 911 for any systemic reactions. 05/05/05 3:00PM- Mother reports reaction is resolving.
Massive Headache, Fever up to 101 for 12 hours, Shivers/chills, Nausea, pain in left leg muscle, pain all over.
intense shoulder, wrist and elbow pain; intense shoulder, wrist and elbow pain; could not lift either arm, couldn't grab the steering wheel, barely made it home; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Apr2021 at 15:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroidism, fibromyalgia, hyperpituitarism, rosacea and ocular rosacea. The patient was allergic to sulfates and antibiotics. Concomitant medications included hydroxychloroquine (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and hydrocortisone (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously took codeine and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 16:15, 30 minutes after the vaccination, the patient experienced intense shoulder, wrist and elbow pain, he could not lift either arm, could not grab the steering wheel and barely made it home. The events lasted over night and when the patient woke up, the pain had gone. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events intense shoulder, wrist and elbow pain and could not lift arm were resolved on 07Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
rough, unusual cough, green/yellow solid mucus clumps being coughed up or expelled when blowing nose, bleeding when blowing nose (unusual for this time of year)
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 31-JUL-2014, the patient was vaccinated with PROQUAD (Merck) (dose strength and route was not reported) (lot # J014235 and expiry date: 07-MAY-2015, reported as 17-MAY-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting PROQUAD (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for PROQUAD (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Headache after 4 days. Pain moves from back of head near neck to front of head near forehead. Pain is acute. Have not taken anything for it.
Initial report received from a health care professional on 20 January 2011.  A female patient (date of birth not reported) with no reported medical history, had received a dose of INFLUENZA (Trade name, manufacturer name, lot number, route and site of administration not reported) on an unspecified day in October 2010.  In January 2011, the patient was diagnosed with Influenza A subtype H3N2.  The reporter did not have any other information regarding vaccination, and declined to provide name and contact information for the patient.  Patient's recovery status was not reported.  Documents held by sender: None.
(L) deltoid area of upper arm, very hot, red & swollen. Not painful, but itchy. Given prescription for MOTRIN & BENADRYL.
Patient was initially vaccinated with Moderna on 3/22/2021, received second dose Pfizer today.  Troubleshooting: Screener, scribe and vaccinator did not validate card;  patient drove past the Pfizer Vaccine Today signs, patient is three days early for vaccine dose. Counseled by RN.
Moderna Bivalent Booster was given but only half of the dose. Wrong dosage given.
pt recvd vax; pt devel lymphadenopathy; headache; fever; stiffness; swelling, joint; asthenia/fatigue; arthralgia; stomatitis;
COVID 19 Treatment.; COVID 19 Treatment.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "ADHD" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19; Negative, notes: Reinfected 5 days after testing negative. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information : The patient received paxlovid for COVID-19 from 08May2023 till 13May2023. No known allergies.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Initial misuse report received from a healthcare professional on 04 September 2013. It was reported that, the patient received ADACEL vaccine on 03 September 2013 which was expired on 02 September 2013. No other information was provided regarding the patient. No adverse event was reported. List of documents held by sender: none.
Per patient representative. Patient developed cellulitis (red, inflamed) and was treated with antibiotics.
Initial report received from a patient on 21 August 2007. A 47-year-old female patient with no pre-existing medical conditions or allergies, had received her third injection in the right deltoid (route not reported) of Imovax Rabies vaccine (lot number not reported) on 23 August 2007 for post exposure prophylaxis and four days later developed numbness and tingling on the left side of her face. The patient not experienced any adverse reactions after the first right deltoid injection or the second left deltoid injection of Imovax Rabies vaccine (lot numbers not reported) on 09 August 2007 and 12 August 2007. The patient also received Imogam Rabies HT in the gluteal muscle and anterior thigh (lot number not reported) on 09 August 2007. On 20 August 2007, four days after she had received the vaccine, the patient developed numbness and tingling on the left side of her face. 24 hours after the onset of symptoms, the patient described the intensity of the numbness and tingling as mild. The patient had not received any concomitant medications at the time of vaccination. She had been scheduled to receive her fourth dose of Imovax Rabies vaccine on 23 August 2007. Information had not been provided regarding the nature of the rabies exposure. The patient had not recovered from the event at the time of the report.
Got the shingles shots and suffered about 3 weeks with shingles/ Suspected vaccination failure; Suffered about 3 weeks with shingles anyway; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shingles shots and suffered about 3 weeks with shingles/ Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Suffered about 3 weeks with shingles anyway). The outcome of the vaccination failure was unknown and the outcome of the shingles was resolved (duration 3 weeks).   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 20-JUN-2023 This case was reported by a patient's neighbor via interactive digital media. Reporter stated (Vax-seens) were a joke. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory test confirming shingles were unknown at the time of reporting.  The follow-up could not be possible as no contact details were available.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates since 088-JAN-2016, the patients were vaccinated with improperly stored doses of ROTATEQ orally (dose, lot # and expiration date were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of -1 degrees Celsius for 220 hours. Time frame/date of excursion, from 08-JAN-2016 to 24-MAY-2016. This is one of several reports received from the same reporter. Additional information has been requested.
Patient reports pain in his upper arm and difficulty moving one of his fingers. Received the vaccine around 9am and states the symptoms started the same day in the afternoon
Reported headache, fatigue, sore arm, cough, sore throat - she called off her next shift due to symptoms.
Soreness of the arm wherethe injection was; Nose is a bit running nonstop; She also feeling tired; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (Patient) reported that a female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number unknown, Expiration date unknown), via an unspecified route of administration on 23Apr2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient experienced soreness of the arm where the injection was, she also felt tired, and her nose was a bit running nonstop. The outcome of the events was unknown.   Information on the lot/batch number has been requested.
Arm started becoming sore that evening, the next day it was extremely sore even to the touch
Vaccine was administered in right deltoid. Approximately 30 minutes later patient experienced hand and arm swelling, redness, and local pain. Treated with ice pack to area. Symptoms alleviated within one hour and resolved within 24 hours.
This spontaneous report as received from a physician (M.D.) via a representative refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with a dose of ZOSTAVAX (dose, route, injection site and lot# not provided). On an unknown date the patient developed shingles. It was not reported that if the patient had sought medical attention. The outcome of shingles was unknown. The physician did not provide the causal relationship between ZOSTAVAX and adverse event. Additional information is not expected.
Psoriasis symptoms; severe psoriatic arthritis affecting the right wrist; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old male patient received bnt162b2 (BNT162B2), on 26Feb2021 as dose 2, single (Lot number: EN6203) at the age of 26 years, in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: bnt162b2 (DOSE 1, SINGLE, Lot number: EL9264, Dose vaccine location: Right arm), administration date: 09Feb2021, when the patient was 26-year-old, for COVID-19 immunization. The following information was reported: PSORIASIS (hospitalization, disability) with onset May2021, outcome "recovered with sequelae", described as "Psoriasis symptoms"; PSORIATIC ARTHROPATHY (medically significant) with onset May2021, outcome "recovered with sequelae", described as "severe psoriatic arthritis affecting the right wrist". The patient was hospitalized for psoriasis (hospitalization duration: 4 day(s)). The events "psoriasis symptoms" and "severe psoriatic arthritis affecting the right wrist" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of psoriasis, psoriatic arthropathy.  Additional information: Psoriasis symptoms beginning in months after vaccine completed. No prior history, no abnormal life events. Psoriasis continued to get worse, with severe psoriatic arthritis affecting the right wrist. Emergency surgery in Jan2022, with ongoing therapy and treatment for psoriasis with COSENTYX to retain functionality. The patient had no covid prior to vaccination. The patient had no known allergies.
On 9/6/00, in the evening, pt developed lumps on his feet. On 9/10/00, had a  temperature of 101.8F (orally) with chills. Lumps on forehead, top of head and around ears and eyes. Lumps have no head or blister top. Itching.
tinnitus/ tinnitus in his ears, specifically the left ear/describes it as "annoying."; tingling in my right leg only like a nerve issue; his right leg he has been "getting shocks" and describes it as intermittent numbness; This is a spontaneous case received from Pfizer sponsored program from a contactable consumer (patient). This 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE), first dose on 20FEB2021, second dose (LOT EN6198) on 13MAR2021, both as single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient was experiencing a constant/ongoing tinnitus/ringing in his ears, more predominantly/specifically in his left ear, the same side as his shot. It started within the week of receiving the 2nd shot. He was also experiencing tingling in his right leg only like a nerve issue. That is sporadic and it doesn't last but it happens everyday now. He had never experienced any symptoms like this until receiving the vaccine and describes it as annoying. The patient also reported that in his right leg he had been "getting shocks" and describes it as intermittent numbness and tingling that occurs once a day. Reporter would like to know how long he should expect this to last or if it is going to be permanent. He stated that he had read online that tinnitus is a side effect of the Pfizer vaccine. He would like to know if this is an expected side effect with the vaccine. His side effect was not listed as a commonly reported side effect in the clinical trials but also let him know that this list does not include all possible side effects. The outcome of the event tinnitus was Not recovered, of others was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Fever, rash and erratic behavior approximately 10 days after the vaccine given.  Symptoms lasted for about a week.
Pt. experiencing anxiety, light headedness and dizziness. B/P 89/54, B/P 101/65